Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2011 1
2016 2
2017 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Postprandial Monocyte Activation in Individuals With Metabolic Syndrome.
Khan IM, Pokharel Y, Dadu RT, Lewis DE, Hoogeveen RC, Wu H, Ballantyne CM. Khan IM, et al. J Clin Endocrinol Metab. 2016 Nov;101(11):4195-4204. doi: 10.1210/jc.2016-2732. Epub 2016 Aug 30. J Clin Endocrinol Metab. 2016. PMID: 27575945 Free PMC article.
MAIN OUTCOME MEASURES: Baseline levels of activation markers and postprandial inflammatory response in each of the three monocyte subsets were measured. ...CONCLUSIONS: Compared to controls, individuals with obesity and MS had increased fasting and …
MAIN OUTCOME MEASURES: Baseline levels of activation markers and postprandial inflammatory response in each of the three mo
Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome.
Rosenson RS, Huskin AL, Wolff DA, Helenowski IB, Rademaker AW. Rosenson RS, et al. Atherosclerosis. 2008 Jun;198(2):381-8. doi: 10.1016/j.atherosclerosis.2007.12.007. Epub 2008 Feb 1. Atherosclerosis. 2008. PMID: 18242616 Clinical Trial.
OBJECTIVE: To examine the effects of fenofibrate (160mg/d) therapy on fasting and postprandial cytokine production in subjects with metabolic syndrome and hypertriglyceridemia. RESEARCH DESIGN AND METHODS: Randomized, double-blind, controlled trial that compa …
OBJECTIVE: To examine the effects of fenofibrate (160mg/d) therapy on fasting and postprandial cytokine production in subjects with …
Effect of a single bout of aerobic exercise on high-fat meal-induced inflammation.
Fuller KNZ, Summers CM, Valentine RJ. Fuller KNZ, et al. Metabolism. 2017 Jun;71:144-152. doi: 10.1016/j.metabol.2017.03.001. Epub 2017 Mar 8. Metabolism. 2017. PMID: 28521867 Clinical Trial.
BACKGROUND AND AIMS: Chronic low-grade inflammation is involved in the development of metabolic disorders including atherosclerosis, type 2 diabetes (T2D) and metabolic syndrome. Aerobic exercise has been shown to be anti-inflammatory and attenuate postpra
BACKGROUND AND AIMS: Chronic low-grade inflammation is involved in the development of metabolic disorders including atherosclerosis, …
Assessment of incretins in oral glucose and lipid tolerance tests may be indicative in the diagnosis of metabolic syndrome aggravation.
Kiec-Klimczak M, Malczewska-Malec M, Razny U, Zdzienicka A, Gruca A, Goralska J, Pach D, Gilis-Januszewska A, Dembinska-Kiec A, Hubalewska-Dydejczyk A. Kiec-Klimczak M, et al. J Physiol Pharmacol. 2016 Apr;67(2):217-26. J Physiol Pharmacol. 2016. PMID: 27226181 Free article.
The study was aimed to compare the release of incretins and some of early markers of inflammation at the fasting and postprandial period induced by functional oral glucose as well as lipid load in healthy controls and patients with metabolic syndrome ( …
The study was aimed to compare the release of incretins and some of early markers of inflammation at the fasting and postprandial
Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks.
Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC, Bremer AA, Berglund L, McGahan JP, Keim NL, Havel PJ. Cox CL, et al. J Clin Endocrinol Metab. 2011 Dec;96(12):E2034-8. doi: 10.1210/jc.2011-1050. Epub 2011 Sep 28. J Clin Endocrinol Metab. 2011. PMID: 21956423 Free PMC article.
OBJECTIVE: Our objective was to determine the effects of 10 wk of dietary fructose or glucose consumption on plasma concentrations of monocyte chemoattractant protein-1 (MCP-1), plasminogen activator inhibitor-1 (PAI-1), E-selectin, intercellular adhesion molecule-1 …
OBJECTIVE: Our objective was to determine the effects of 10 wk of dietary fructose or glucose consumption on plasma concentrations of mon
Feedback